• Protease Inhibitor Cocktail for Liver Protein Workflows

  2026-09-29

  Protect liver and macrophage proteins during disruption with an EDTA-free, broad-spectrum formulation suited to Western blotting, co-immunoprecipitation, kinase assays, and other cation-sensitive workflows. This guide connects practical sample handling with the macrophage and inflammasome findings reported in a Mallory-Denk body model.

• 2,7-Dichlorodihydrofluorescein diacetate ROS Workflow

  2026-09-29

  Build a practical DCFH-DA workflow for fluorescence microscopy, flow cytometry, and plate-based oxidative stress assays. The guide connects intracellular ROS measurement with the THBS1/PI3K/AKT findings in granulosa-cell research while emphasizing controls, normalization, and probe-specific limitations.

• Angiotensin I: From Precursor to Translation

  2026-09-28

  Angiotensin I is more than an intermediate in the renin-angiotensin system. As a defined ACE substrate, it enables researchers to separate peptide conversion from downstream receptor signaling and build more interpretable cardiovascular, neuroendocrine, and antihypertensive drug studies.

• Polygodial for TRPA1 Channel Research

  2026-09-28

  Use Polygodial to probe TRPA1-dependent calcium signaling, then connect channel activation to NFAT localization and epithelial inflammatory readouts. This workflow turns a channel-level response into a testable signaling sequence while emphasizing controls that distinguish TRPA1 effects from solvent, cell-state, and downstream pathway effects.

• Natural-Product Screening Identifies NSP15 Binders

  2026-09-27

  Vijayan and Gourinath used structure-based virtual screening and molecular dynamics to prioritize thymopentin and oleuropein as candidate binders of the SARS-CoV-2 endoribonuclease NSP15. The results provide a computational starting point for inhibitor testing, but do not establish antiviral activity or clinical efficacy.

• DAF-2 Diacetate for Nitric Oxide Imaging

  2026-09-26

  DAF-2 diacetate turns intracellular NO-related chemistry into a retained fluorescent readout for live cells and complex tissues. Applied to soybean nodules, it can complement sulfur-transport and senescence measurements—but fluorescence should be interpreted as a pathway-sensitive signal, not a direct NO concentration.

• Perospirone: From Receptor Pharmacology to Kv Channels

  2026-09-25

  Perospirone (SM-9018 free base) is best understood as more than a receptor probe: recent electrophysiology identifies a concentration-dependent effect on vascular Kv currents. This article explains what the finding supports, where evidence remains preliminary, and how to design assays that separate established receptor pharmacology from emerging off-target questions.

• Firefly Luciferase mRNA for Delivery Assays

  2026-09-25

  Use a bright, transient reporter signal to compare mRNA delivery conditions, translation, and cell responses in one adaptable workflow. This guide connects the product’s Cap1, 5-moUTP, and poly(A) design with practical controls, troubleshooting, and lessons from newer low-inflammatory LNP research.

• Tetrandrine: From Ion-Channel Probe to Translation

  2026-09-24

  A mechanism-first guide to using Tetrandrine in translational research: connect calcium-channel modulation to testable cellular hypotheses, design stronger validation workflows, and interpret natural-product screening without overstating what it proves.

• Actinomycin D in AML: From Transcription to Translation

  2026-09-24

  A strategic guide to using Actinomycin D in AML research: connect transcriptional shutoff to RNA-stability questions, interpret WTAP–m6A findings carefully, and design experiments that distinguish RNA turnover from broader cellular stress.

• Angiotensin II, Ferroptosis, and NPC Radioresistance

  2026-09-23

  A study in nasopharyngeal carcinoma links locally produced angiotensin II to radioresistance through an AGT–HIF-1α–HILPDA circuit that limits ferroptosis. Its findings support investigating angiotensin receptor blockade alongside ferroptosis induction, while the proposed pathway biomarkers and treatment strategy still require clinical validation.

• Firefly Luciferase mRNA as a Translation Benchmark

  2026-09-23

  Firefly Luciferase mRNA can do more than generate a bright reporter signal: it can help separate delivery, translation, and protein-function variables. This article connects the R1013 design with chemically modified mRNA research and provides a decision framework for reproducible assay interpretation.

• CX-5461 RNA Polymerase I Inhibitor Workflow

  2026-09-22

  Build a mechanism-led CX-5461 workflow that links Pol I-driven rRNA suppression with DNA damage, mitotic catastrophe, autophagy, and senescence. Practical formulation, assay-selection, combination-testing, and troubleshooting guidance supports reproducible cancer research from cultured cells to solid-tumor models.

• Nuclear cGAS and L1 Retrotransposition Control

  2026-09-22

  The reference study identifies nuclear cGAS as a genome-protective suppressor of LINE-1 retrotransposition, acting through CHK2-dependent recruitment of the E3 ligase TRIM41 and degradation of ORF2p. Its findings connect DNA damage signaling, transposable-element control, senescence, and cancer-associated cGAS mutations, while providing a mechanistic framework for future DNA damage response studies.

• L1023 Anti-Cancer Compound Library for Cancer Research

  2026-09-21

  The L1023 Anti-Cancer Compound Library provides 1164 pre-dissolved bioactive compounds for cancer research and high-throughput screening. Its pathway coverage supports comparative studies of BRAF kinase inhibitor activity, mTOR signaling pathway regulation, apoptosis, and other oncogenic processes.

8424 records 1/562 page Next 12345 下5页 Last page